
Will BRAVYL Reduce “Wandering” in Advanced Clinical Trials?
Woolsey Pharmaceuticals on Feb. 18, 2021 announced the launch of a Phase 2 CNS study of a medication intended to reduce wandering in dementia patients.
Woolsey Pharmaceuticals on Feb. 18, 2021 announced the launch of a Phase 2 CNS study of a medication intended to reduce wandering in dementia patients.
Please enter your request in the comments box below.
Get your message out with Alzheimer’s Weekly! Publish your news prominently on AlzheimersWeekly.com and email it to 30,000 opt-in subscribers. The fee is just $100.
VIDEO + ARTICLE: Scientists are applying an FDA-approved technique, Deep Brain Stimulation, to treat mild Alzheimer’s for 150 patients in Phase-3 clinical trials. Learn more.
Researchers in Australia conduct animal experiments showing more easily absorbed nanoparticles that contain curcumin, from turmeric, not only prevent cognitive deterioration, but also reverse the
NUTRITION VIDEO + ARTICLE: Recently, the FDA Slammed 58 Dangerous Alzheimer’s Supplements. Who are the culprits? Why did it happen? See this list and watch
All I want is for you, To forever remember me as loving you. VALENTINES DAY GIFT IDEA: Order this message on a pillow, card, shirt,
MEDICATION VIDEO + ARTICLE: Scientists found drug developed for diabetes “significantly reversed memory loss” in Alzheimer’s mice, through a triple method of action. See why
CLINICAL TRIALS: Find out why researchers think spraying nasal insulin through the nose can improve cognition, memory and daily function in people with Alzheimer’s. Learn
BOOK OF THE WEEK: This is one of the very few books written for people with dementia. It is designed to ease a person along
VIDEO + ARTICLE: Residential areas with more green space were associated with faster thinking, better attention, and higher overall cognitive function in a federal study. Learn more.
Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.
Alzheimer’s is characterized by an overproduction of free radicals in cells. That’s why incredibly tiny “nanoparticles” of silver, found in supplements, cosmetics and food packaging, worry scientists. Hear their concerns, as well as products to avoid.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.